---
kind: "section"
citation: "40 C.F.R. § 266.508"
title: "40"
number: "266.508"
heading: "Shipping non-creditable hazardous waste pharmaceuticals from a healthcare facility or evaluated hazardous waste pharmaceuticals from a reverse distributor."
url: "https://uscodex.org/cfr/40/266.508"
---

# §266.508. Shipping non-creditable hazardous waste pharmaceuticals from a healthcare facility or evaluated hazardous waste pharmaceuticals from a reverse distributor.

- (a) **Shipping non-creditable hazardous waste pharmaceuticals or evaluated hazardous waste pharmaceuticals.** A healthcare facility must ship non-creditable hazardous waste pharmaceuticals and a reverse distributor must ship evaluated hazardous waste pharmaceuticals off-site to a designated facility (such as a permitted or interim status treatment, storage, or disposal facility) in compliance with:
  - (1) **The following pre-transport requirements, before transporting or offering for transport off-site—**
    - (i) **Packaging.** Package the waste in accordance with the applicable Department of Transportation regulations on hazardous materials under 49 CFR parts [173](/cfr/49/part173.md), [178](/cfr/49/part178.md), and 180.
    - (ii) **Labeling.** Label each package in accordance with the applicable Department of Transportation regulations on hazardous materials under [49 CFR part 172](/cfr/49/part172.md) subpart E.
    - (iii) **Marking.**
      - (A) Mark each package of hazardous waste pharmaceuticals in accordance with the applicable Department of Transportation (DOT) regulations on hazardous materials under [49 CFR part 172](/cfr/49/part172.md) [subpart D](/cfr/40/subpartD.md);
      - (B) Mark each container of 119 gallons or less used in such transportation with the following words and information in accordance with the requirements of [49 CFR 172.304](/cfr/49/172.304.md):

        HAZARDOUS WASTE—Federal Law Prohibits Improper Disposal. If found, contact the nearest police or public safety authority or the U.S. Environmental Protection Agency.

      - (C) Lab packs that will be incinerated in compliance with [§ 268.42(c)](/cfr/40/268.42.md?p=c) of this subchapter are not required to be marked with EPA hazardous waste numbers (i.e., hazardous waste codes), except D004, D005, D006, D007, D008, D010, and D011, where applicable. A nationally recognized electronic system, such as bar coding or radio frequency identification tag, may be used to identify the applicable EPA hazardous waste numbers (i.e., hazardous waste codes).
    - (iv) **Placarding.** Placard or offer the initial transporter the appropriate placards according to Department of Transportation regulations for hazardous materials under [49 CFR part 172](/cfr/49/part172.md) subpart F.
  - (2) **The manifest requirements of 40 CFR part 262 subpart B, except that—**
    - (i) A healthcare facility shipping noncreditable hazardous waste pharmaceuticals is not required to list all applicable EPA hazardous waste numbers (i.e., hazardous waste codes) in Item 13 of EPA Form 8700-22.
    - (ii) A healthcare facility shipping non-creditable hazardous waste pharmaceuticals must write the word “PHRM” or “PHARMS” in Item 13 of EPA Form 8700-22. A healthcare facility may also include the applicable EPA hazardous waste numbers (i.e., hazardous waste codes) in Item 13 of EPA Form 8700-22.
- (b) **Exporting non-creditable hazardous waste pharmaceuticals or evaluated hazardous waste pharmaceuticals.** A healthcare facility or reverse distributor that exports non-creditable hazardous waste pharmaceuticals or evaluated hazardous waste pharmaceuticals is subject to [40 CFR part 262](/cfr/40/part262.md) subpart H.
- (c) **Importing non-creditable hazardous waste pharmaceuticals or evaluated hazardous waste pharmaceuticals.** Any person that imports non-creditable hazardous waste pharmaceuticals or evaluated hazardous waste pharmaceuticals is subject to [40 CFR part 262](/cfr/40/part262.md) subpart H. A healthcare facility or reverse distributor may not accept imported non-creditable hazardous waste pharmaceuticals or evaluated hazardous waste pharmaceuticals unless they have a permit or interim status that allows them to accept hazardous waste from off site.

## Notes

### Amendments

[84 FR 5940, Feb. 22, 2019, as amended at 88 FR 54113, Aug. 9, 2023; 88 FR 84713, Dec. 6, 2023; 89 FR 99732, Dec. 11, 2024]

### Source

Source: 84 FR 5940, Feb. 22, 2019, unless otherwise noted.

### Authority

Authority: 42 U.S.C. 1006, 2002(a), 3001-3009, 3014, 3017, 6905, 6906, 6912, 6921, 6922, 6924-6927, 6934, and 6937.

### Source

Source: 50 FR 666, Jan. 4, 1985, unless otherwise noted.

### Amendments

[84 FR 5940, Feb. 22, 2019, as amended at 88 FR 54113, Aug. 9, 2023; 88 FR 84713, Dec. 6, 2023; 89 FR 99732, Dec. 11, 2024]